ADVANCE Study FAQ

To examine the use of Varenicline (Chantix) to reduce alcohol consumption in heavy drinking smokers.collapse
The medication is called Varenicline. It is FDA-approved as a smoking cessation medication. In this study, we are examining the use of Varenicline to reduce alcohol consumption.collapse
Varenicline was not designed to cause this reaction. While nausea can occur with Varenicline, it is usually mild and typically goes away over time. A different medication, called disulfiram or antabuse is designed to make someone sick if they drink alcohol while taking it. Again, this is not the medication used in this study.collapse
Varenicline has been approved by the FDA as a smoking cessation medication. In our study, we are examining the use of Varenicline to reduce alcohol consumption. Like any medication, its use may lead to side effects such as nausea and it must be used as directed. Details about the medication and how it should be taken would be explained to you by the study nurse. You can always contact us with any questions or concerns about the medication.collapse
You will take a 2mg dose each day.collapse
The study lasts about one year.collapse
There are a total of 17 appointments for the study over the course of a year at our study site at 1 Long Wharf Drive in New Haven.collapse
You can earn up to $525 while participating in the ADVANCE Study.collapse
Call us at (203) 859-8643 or email us at advance@yale.edu.collapse